Takeaway

• Inhaled bronchodilators do not improve respiratory symptoms in symptomatic, tobacco-exposed individuals with preserved spirometry, only those with lung damage enough to disrupt normal spirometry readings benefit from bronchodilator therapy.

A long-acting bronchodilator is the first choice for therapy in patients with chronic obstructive pulmonary disease (COPD). Spirometry shows evidence...